In this February 18 segment, pharmacist Nemire explains why it’s time to elevate the role of pharmacists in clinical trials, how industry will benefit, and why it’s been a struggle to get this right.
Technology has become an integral part of clinical trial operations, and it’s high time those personnel tasked with handling and managing it were better trained and recognized for their efforts, says Bree Burks, RN, MSN, vice president of strategy in the site solutions realm with Veeva Systems. “We haven’t done a good job in this […]
Researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA), and the American Association for Cancer Research (AACR) are releasing recommendations designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites. The initiative, published […]
Translating laboratory discoveries to clinical care for patients with cancer is a difficult process. Much of the effort is carried by researchers who are also trained as physicians, especially a subgroup known as clinician investigators. However, according to results of a survey by the Association of American Cancer Institutes (AACI), the work of clinician […]
Clinical research organizations face a seemingly bewildering array of financial and regulatory demands, but there’s light at the end of the tunnel for those who proactively develop compliance programs, says Mary Veazie, MBA, CPA, CHC, CHRC, executive director for Clinical Research Finance at The University of Texas MD Anderson Cancer Center. It’s a chronic challenge […]
